Biofrontera Inc. to Report Second Quarter Financial Results on August 12, 2022
August 04 2022 - 8:30AM
Biofrontera
Inc. (Nasdaq: BFRI),
a biopharmaceutical company specializing in the commercialization
of dermatological products, announces it will report financial
results for the three and six months ended June 30, 2022 before the
opening of the U.S. financial markets on Friday, August 12, 2022.
The Company will hold a conference call that same day beginning at
11:00 a.m. Eastern time to discuss those results, provide a
business update and answer questions.
Conference Call and Webcast
Information
Event: |
Biofrontera Inc. Second Quarter 2022 Financial Results and Business
Update Conference Call |
Date: |
Friday, August 12, 2022 |
Time: |
11:00 a.m. Eastern time |
Conference call: |
1-877-877-1275 (U.S.)1-412-858-5202 (international) |
Webcast: |
Live and 90-day replay webcast are available here and at
www.investors.biofrontera-us.com. |
About Biofrontera Inc.
Biofrontera Inc. is a U.S.-based
biopharmaceutical company commercializing a portfolio of
pharmaceutical products for the treatment of dermatological
conditions with a focus on photodynamic therapy (PDT) and topical
antibiotics. The Company’s licensed products are used for the
treatment of actinic keratoses, which are pre-cancerous skin
lesions, as well as impetigo, a bacterial skin infection. For more
information, visit www.biofrontera-us.com.
Contacts
Biofrontera Inc.Anke zur
Mühlen+1 781 486 1539us-ir@biofrontera.com
LHA Investor RelationsTirth T.
Patel+1 212 201 6614tpatel@lhai.com
###
Biofrontera (NASDAQ:BFRIW)
Historical Stock Chart
From Jun 2024 to Jul 2024
Biofrontera (NASDAQ:BFRIW)
Historical Stock Chart
From Jul 2023 to Jul 2024